Boston, January 20, 2026 — Velsera today announced the appointment of James M. Coffin, PhD (Jamie), a seasoned leader in life sciences and healthcare technology, as its new President and Chief Executive Officer, effective February 1, 2026.
Dr. Coffin brings more than 25 years of leadership experience from organizations including IBM Life Sciences, Dell Healthcare and Life Sciences, Source Medical, and Sema4. Throughout his career, he has focused on advancing data-driven technologies that enable personalized medicine. His passion for improving patient care aligns strongly with Velsera’s mission.
Velsera, founded on the combined strengths of Seven Bridges (Seven Bridges Platform, Cancer Genomics Cloud, BioData Catalyst and CAVATICA), Pierian (CGW) and UgenTec (FastFinder) delivers powerful platforms that enable researchers and clinicians to transform complex biological data into actionable insights across discovery, translational research, and precision medicine. In 2025 Velsera (also) launched a global data network to provide pharma clients with clinicogenomic data to support and accelerate drug discovery.
“Velsera operates at a pivotal intersection of biology, personalized medicine and multi-omic data,” said Jamie Coffin, PhD. “The company brings together proven technology, deep scientific expertise, and an exceptional team. The opportunity to build on the strong foundations of Seven Bridges, Pierian and UgenTec and to shape their next phase of growth is incredibly exciting. I look forward to working with the team to expand our impact for patients and our clients worldwide.”
“Jamie brings the strategic vision, the passion for this incredibly exciting space, a deep focus on the customer and the scientific depth to guide Velsera forward,” said Stephanie Caspar, Chair of Velsera. “On behalf of the Board, I am delighted to welcome him as CEO and confident in his ability to lead the company forward.”
About Velsera
Velsera is a global bioinformatics company founded on the combined strengths of Seven Bridges, Pierian and UgenTec. Velsera provides integrated data and analytic platforms that empower life sciences organizations to accelerate discovery, translational research, and precision medicine.
Media Contact:
Pavel Gongora
Pavel.Gongora@velsera.com